Market Overview:
The global noproxen market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic diseases, increasing awareness about pain management, and growing demand for noproxen in emerging markets. However, the high cost of treatment and side effects associated with noproxen are some of the major factors that could hamper the growth of this market during the forecast period.
Product Definition:
Noproxen is a medication used to treat pain, inflammation, and fever. It is a nonsteroidal anti-inflammatory drug (NSAID).
Powder:
Powder is a fine, white crystalline powder and is soluble in water. It has the ability to reduce pain by acting as an anti-inflammatory drug. Powder form of the drug can be administered directly into the vein or it can be mixed with drinks, food or tablets.
Granules:
Granules are the dry particles that remain after pulverization of anhydrous drug substance. Granules are used in the manufacturing of generic medicines. They have a wide range of applications such as oral solid dosage forms, injections, and parenteral solutions among others.
Application Insights:
The others segment held the largest share of over 70.0% in 2017. The product is used as an active pharmaceutical ingredient (API) in the manufacture of various drugs including nasal sprays, eye drops, gels and lotions for external use on the skin, and oral solutions for inhalation by mouth. These products are also used as a cooking oil due to its high smoke point which makes it suitable for deep-frying foods such as chicken wings and French fries among other foods that require a thickener additive.
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand from the pharmaceutical, animal feed and food & beverage sectors. The region is expected to maintain its dominance over the forecast period due to increasing cases of arthritis and other joint problems. Asia Pacific is estimated to be one of the fastest-growing regions during the forecast years on account of rising product consumption in countries such as China, India, Japan, South Korea and Taiwan. In addition, growing production facilities by major companies coupled with low manufacturing costs will drive regional growth further.
The European market for noproxen was valued at USD X million in 2017 owing to high consumer awareness regarding health along with changing lifestyles has resulted into increased demand for pain relief products such as tablets and capsules among others which includes powder forms.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for noproxen in the coming years.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as arthritis, osteoarthritis, and others is on the rise globally and this is expected to boost the demand for noproxen in the near future.
- Growing awareness about benefits of noproxen: There has been a growing awareness about the benefits of using noproxen among consumers in recent years which is likely to propel its market growth in the coming years.
- Technological advancements: The development of novel technologies that can improve delivery methods for noproxen are likely to create new opportunities for growth in this market over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Noproxen Market Research Report
By Type
Powder, Granules,
By Application
Tablet Drug, Granules Drug, Oral Solution, Others,
By Companies
Atnahs Pharma Uk Limited, Roche Laboratories Inc., Syntex Inc., Apotex Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Noproxen Market Report Segments:
The global Noproxen market is segmented on the basis of:
Types
Powder, Granules,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet Drug, Granules Drug, Oral Solution, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Atnahs Pharma Uk Limited
- Roche Laboratories Inc.
- Syntex Inc.
- Apotex Corporation
Highlights of The Noproxen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Granules
- By Application:
- Tablet Drug
- Granules Drug
- Oral Solution
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Noproxen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Noproxen is a nonsteroidal anti-inflammatory drug (NSAID) that is used to relieve pain and inflammation. It is available in over-the-counter (OTC) forms. Noproxen may also be marketed under the brand names Naprosyn, Aleve, and Anaprox.
Some of the major players in the noproxen market are Atnahs Pharma Uk Limited, Roche Laboratories Inc., Syntex Inc., Apotex Corporation.
The noproxen market is expected to grow at a compound annual growth rate of 3.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Noproxen Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Noproxen Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Noproxen Market - Supply Chain
4.5. Global Noproxen Market Forecast
4.5.1. Noproxen Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Noproxen Market Size (000 Units) and Y-o-Y Growth
4.5.3. Noproxen Market Absolute $ Opportunity
5. Global Noproxen Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Noproxen Market Size and Volume Forecast by Type
5.3.1. Powder
5.3.2. Granules
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Noproxen Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Noproxen Market Size and Volume Forecast by Application
6.3.1. Tablet Drug
6.3.2. Granules Drug
6.3.3. Oral Solution
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Noproxen Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Noproxen Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Noproxen Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Noproxen Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Noproxen Demand Share Forecast, 2019-2026
9. North America Noproxen Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Noproxen Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Noproxen Market Size and Volume Forecast by Application
9.4.1. Tablet Drug
9.4.2. Granules Drug
9.4.3. Oral Solution
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Noproxen Market Size and Volume Forecast by Type
9.7.1. Powder
9.7.2. Granules
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Noproxen Demand Share Forecast, 2019-2026
10. Latin America Noproxen Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Noproxen Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Noproxen Market Size and Volume Forecast by Application
10.4.1. Tablet Drug
10.4.2. Granules Drug
10.4.3. Oral Solution
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Noproxen Market Size and Volume Forecast by Type
10.7.1. Powder
10.7.2. Granules
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Noproxen Demand Share Forecast, 2019-2026
11. Europe Noproxen Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Noproxen Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Noproxen Market Size and Volume Forecast by Application
11.4.1. Tablet Drug
11.4.2. Granules Drug
11.4.3. Oral Solution
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Noproxen Market Size and Volume Forecast by Type
11.7.1. Powder
11.7.2. Granules
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Noproxen Demand Share, 2019-2026
12. Asia Pacific Noproxen Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Noproxen Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Noproxen Market Size and Volume Forecast by Application
12.4.1. Tablet Drug
12.4.2. Granules Drug
12.4.3. Oral Solution
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Noproxen Market Size and Volume Forecast by Type
12.7.1. Powder
12.7.2. Granules
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Noproxen Demand Share, 2019-2026
13. Middle East & Africa Noproxen Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Noproxen Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Noproxen Market Size and Volume Forecast by Application
13.4.1. Tablet Drug
13.4.2. Granules Drug
13.4.3. Oral Solution
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Noproxen Market Size and Volume Forecast by Type
13.7.1. Powder
13.7.2. Granules
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Noproxen Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Noproxen Market: Market Share Analysis
14.2. Noproxen Distributors and Customers
14.3. Noproxen Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Atnahs Pharma Uk Limited
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche Laboratories Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Syntex Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Apotex Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
